MX2008007195A - Inhibidores de proteasas de cisteina, composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas. - Google Patents
Inhibidores de proteasas de cisteina, composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas.Info
- Publication number
- MX2008007195A MX2008007195A MX2008007195A MX2008007195A MX2008007195A MX 2008007195 A MX2008007195 A MX 2008007195A MX 2008007195 A MX2008007195 A MX 2008007195A MX 2008007195 A MX2008007195 A MX 2008007195A MX 2008007195 A MX2008007195 A MX 2008007195A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitors
- pharmaceutical compositions
- therapeutic applications
- cysteine proteases
- proteases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Abstract
La presente invención se relaciona con compuestos nuevos de fórmula (I), sus procesos de preparación y su uso terapéutico.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05292612A EP1798232A1 (en) | 2005-12-08 | 2005-12-08 | Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
US11/296,564 US7462615B2 (en) | 2005-12-08 | 2005-12-08 | Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
PCT/IB2006/003475 WO2007066200A2 (en) | 2005-12-08 | 2006-12-05 | Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008007195A true MX2008007195A (es) | 2008-09-10 |
Family
ID=38006777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008007195A MX2008007195A (es) | 2005-12-08 | 2006-12-05 | Inhibidores de proteasas de cisteina, composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1963328B1 (es) |
JP (1) | JP5173829B2 (es) |
AU (1) | AU2006322958B2 (es) |
CA (1) | CA2632635C (es) |
ES (1) | ES2439456T3 (es) |
IL (1) | IL191992A (es) |
MX (1) | MX2008007195A (es) |
NZ (1) | NZ568805A (es) |
RU (1) | RU2440351C2 (es) |
WO (1) | WO2007066200A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2667839C (en) * | 2006-10-30 | 2016-01-12 | Hybrigenics Sa | Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
EP2208725A1 (en) * | 2009-01-13 | 2010-07-21 | Hybrigenics S.A. | Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
WO2011069149A2 (en) | 2009-12-04 | 2011-06-09 | Dcb-Usa Llc | Cathepsin s inhibitors |
IL303195A (en) | 2020-11-25 | 2023-07-01 | Akagera Medicines Inc | Lipid nanoparticles for delivery of nucleic acids and related methods of use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405619A (en) * | 1981-09-02 | 1983-09-20 | Diamond Shamrock Corporation | Antiinflammatory substituted-1,2,4-triazolo[4,3-b]-1,2,4-triazines |
FR2722789B1 (fr) * | 1994-07-20 | 1996-08-23 | Rhone Poulenc Rorer Sa | Derives d'acide imidazo (1,2-a)indeno(1,2-e) pyrazine-2-carboxylique, leur preparation et les medicaments les contenant |
JP2002539162A (ja) * | 1999-03-12 | 2002-11-19 | アベンテイス・フアルマ・ソシエテ・アノニム | リルゾールおよびampa受容体アンタゴニストの組み合わせ剤を用いる筋萎縮性側索硬化症の治療 |
AU2001240021A1 (en) * | 2000-04-13 | 2001-10-30 | Millennium Pharmaceuticals, Inc. | Diazafluorenone il-8 receptor antagonists |
US6514972B2 (en) * | 2000-07-06 | 2003-02-04 | Kinetek Pharmaceuticals, Inc. | Heteropolycyclic inhibitors of protein kinases |
-
2006
- 2006-12-05 AU AU2006322958A patent/AU2006322958B2/en not_active Ceased
- 2006-12-05 WO PCT/IB2006/003475 patent/WO2007066200A2/en active Application Filing
- 2006-12-05 CA CA2632635A patent/CA2632635C/en not_active Expired - Fee Related
- 2006-12-05 EP EP06831646.2A patent/EP1963328B1/en not_active Not-in-force
- 2006-12-05 ES ES06831646.2T patent/ES2439456T3/es active Active
- 2006-12-05 MX MX2008007195A patent/MX2008007195A/es active IP Right Grant
- 2006-12-05 NZ NZ568805A patent/NZ568805A/en not_active IP Right Cessation
- 2006-12-05 JP JP2008543932A patent/JP5173829B2/ja not_active Expired - Fee Related
- 2006-12-05 RU RU2008127502/04A patent/RU2440351C2/ru not_active IP Right Cessation
-
2008
- 2008-06-05 IL IL191992A patent/IL191992A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2440351C2 (ru) | 2012-01-20 |
NZ568805A (en) | 2011-06-30 |
CA2632635C (en) | 2014-04-29 |
JP2009518383A (ja) | 2009-05-07 |
RU2008127502A (ru) | 2010-01-20 |
AU2006322958A1 (en) | 2007-06-14 |
EP1963328A2 (en) | 2008-09-03 |
ES2439456T3 (es) | 2014-01-23 |
WO2007066200A3 (en) | 2007-09-07 |
EP1963328B1 (en) | 2013-10-30 |
CA2632635A1 (en) | 2007-06-14 |
AU2006322958B2 (en) | 2012-06-07 |
WO2007066200A2 (en) | 2007-06-14 |
JP5173829B2 (ja) | 2013-04-03 |
IL191992A0 (en) | 2008-12-29 |
IL191992A (en) | 2016-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0301700D0 (sv) | Novel compounds | |
MX2009000884A (es) | Derivados de piridizinona. | |
TW200801003A (en) | Novel compounds | |
TW200800999A (en) | Novel compounds | |
TW200716606A (en) | Chemical compounds | |
TW200800963A (en) | Chemical compounds | |
HK1113352A1 (en) | Chemical compounds | |
HK1114375A1 (en) | Chemical compounds | |
TW200738659A (en) | Novel compounds | |
TW200745122A (en) | New compounds I | |
TW200745084A (en) | Novel compounds | |
MX2009008925A (es) | Compuestos de la formula (i) como inhibidores de proteasa de serina. | |
TW200716529A (en) | New compounds II | |
TW200736227A (en) | New compounds III | |
TW200635916A (en) | Compounds | |
TW200616977A (en) | Enantiomers of selected fused heterocyclics and uses thereof | |
TW200730512A (en) | Novel compounds | |
IL189286A0 (en) | Novel cysteine protease inhibitors and their therapeutic applications | |
TW200621260A (en) | Selected fused heterocyclics and uses thereof | |
TW200624429A (en) | Novel cysteine protease inhibitors | |
TW200745133A (en) | New compounds II | |
WO2007025774A3 (en) | Cysteine protease inhibitors | |
TW200720262A (en) | Novel compounds ii | |
MX2008007195A (es) | Inhibidores de proteasas de cisteina, composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas. | |
MX2007013305A (es) | Nuevas tiazolidinonas sin nitrogeno basico, su produccion y su uso como agentes farmaceuticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |